|
Hematologic Malignancies FY17 |
07/01/2016 - 9:00am to 10:00am EDT |
|
Hematologic Malignancies FY17 |
07/08/2016 - 9:00am to 10:00am EDT |
|
Hematologic Malignancies FY17 |
07/15/2016 - 9:00am to 10:00am EDT |
|
Hematologic Malignancies FY17 |
07/22/2016 - 9:00am to 10:00am EDT |
|
Hematologic Malignancies FY17 CNS toxicities of immune therapies |
07/29/2016 - 9:00am to 10:00am EDT |
|
Hematologic Malignancies FY17 |
08/05/2016 - 9:00am to 10:00am EDT |
|
Hematologic Malignancies FY17 Elderly Acute Myeloid Leukemia: Paradigm Shift or Not |
08/12/2016 - 9:00am to 10:00am EDT |
|
Hematologic Malignancies FY17 Personalized therapeutic approaches for patients with hematologic malignancies |
08/19/2016 - 9:00am to 10:00am EDT |
|
Hematologic Malignancies FY17 Duodenal-type Follicular Lymphoma. A new 2016 WHO Entity |
08/26/2016 - 9:00am to 10:00am EDT |
|
Hematologic Malignancies FY17 Thinking About Follicular Lymphoma, Grade 3a or 3b |
09/02/2016 - 9:00am to 10:00am EDT |
Facebook
X
LinkedIn
Forward